Nutrien Ltd.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Nutrien Ltd. reported revenue of $26.9B (+3.5% year on year) and net income of $2.3B (+228.1% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| GROSS MARGIN | $8.3B | $7.5B | $8.5B | $15.4B |
| SALES (Note 3) | $26.9B | $26.0B | $29.1B | $37.9B |
| Freight, transportation and distribution (Note 4) | $936.0M | $956.0M | $974.0M | $872.0M |
| Cost of goods sold (Note 4) | $17.6B | $17.5B | $19.6B | $21.6B |
| Other expenses (income) (Note 6) | $448.0M | $413.0M | $548.0M | $204.0M |
| EARNINGS BEFORE FINANCE COSTS AND INCOME TAXES | $3.7B | $1.9B | $2.7B | $10.8B |
| Finance costs (Note 7) | $687.0M | $720.0M | $793.0M | $563.0M |
| EARNINGS BEFORE INCOME TAXES | $3.0B | $1.1B | $2.0B | $10.2B |
| Income tax (recovery) expense (Note 8) | $752.0M | $436.0M | $670.0M | $2.6B |
| NET EARNINGS | $2.3B | $700.0M | $1.3B | $7.7B |
| Attributable to owners of parent | $2.3B | $674.0M | $1.3B | $7.7B |
| Attributable to non-controlling interests | $30.0M | $26.0M | $24.0M | $27.0M |
| Basic | $4.66 | $1.36 | $2.53 | $14.22 |
| Diluted | $4.66 | $1.36 | $2.53 | $14.18 |
| Weighted average shares outstanding for basic EPS (Note 9) | $486335000.00 | $494198000.00 | $496381000.00 | $538475000.00 |
| Weighted average shares outstanding for diluted EPS (Note 9) | $486518000.00 | $494365000.00 | $496994000.00 | $540010000.00 |
| Selling expenses (Note 4) | $3.3B | $3.4B | $3.4B | $3.4B |
| General and administrative expenses (Note 4) | $600.0M | $644.0M | $626.0M | $565.0M |
| Provincial Mining Taxes Expense | $372.0M | $255.0M | $398.0M | — |
| Impairment (Reversal of impairment) of assets | $0 | $530.0M | $774.0M | ($780.0M) |
| Compensation expense | ($163.0M) | ($37.0M) | — | — |
| Pre-tax gain | ($301.0M) | — | — | — |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $701.0M | $853.0M | $941.0M | $901.0M |
| Receivables (Note 11) | $5.7B | $5.4B | $5.4B | $6.2B |
| Inventories (Note 12) | $7.0B | $6.1B | $6.3B | $7.6B |
| Prepaid expenses and other current assets | $1.4B | $1.4B | $1.5B | $1.6B |
| Current assets | $14.7B | $13.8B | $14.2B | $16.3B |
| Goodwill (Note 14) | $12.1B | $12.0B | $12.1B | $12.4B |
| Other intangible assets (Note 14) | $1.7B | $1.8B | $2.2B | $2.3B |
| Other assets (Note 16) | $858.0M | $884.0M | $1.1B | $969.0M |
| Property, plant and equipment | $22.7B | $22.6B | $22.5B | — |
| Investments accounted for using equity method and in subsidiaries joint ventures and associates | $144.0M | $698.0M | — | — |
| TOTAL ASSETS | $52.3B | $51.8B | $52.7B | $54.6B |
| Short-term debt (Note 17) | $873.0M | $1.5B | $1.8B | $2.1B |
| Current portion of long-term debt (Note 18) | $513.0M | $1.0B | $512.0M | $542.0M |
| Payables and accrued charges (Note 20) | $9.3B | $9.1B | $9.5B | $11.3B |
| Current portion of lease liabilities | $346.0M | $356.0M | $327.0M | $305.0M |
| Current liabilities | $11.0B | $12.0B | $12.1B | $14.3B |
| Long-term debt (Note 18) | $9.3B | $8.9B | $8.9B | $8.0B |
| Lease liabilities - non-current | $937.0M | $999.0M | $999.0M | $899.0M |
| Deferred income tax liabilities (Note 8) | $3.7B | $3.5B | $3.6B | $3.5B |
| Pension and other post-retirement benefit liabilities (Note 21) | $221.0M | $227.0M | $252.0M | $319.0M |
| Asset retirement obligations and accrued environmental costs (Note 22) | $1.5B | $1.5B | $1.5B | $1.4B |
| Other non-current liabilities | $253.0M | $164.0M | $200.0M | $235.0M |
| TOTAL LIABILITIES | $26.9B | $27.4B | $27.5B | $28.7B |
| Share capital (Note 23) | $13.5B | $13.7B | $13.8B | $14.2B |
| Contributed surplus | $57.0M | $68.0M | $83.0M | $109.0M |
| Accumulated other comprehensive loss | ($329.0M) | ($515.0M) | ($296.0M) | ($391.0M) |
| Retained earnings | $12.1B | $11.1B | $11.5B | $11.9B |
| Non-controlling interests | $42.0M | $35.0M | $45.0M | $45.0M |
| Equity attributable to owners of parent | $25.3B | $24.4B | $25.2B | $25.8B |
| TOTAL SHAREHOLDERS' EQUITY | $25.4B | $24.4B | $25.2B | $25.9B |
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | $52.3B | $51.8B | $52.7B | $54.6B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| CASH PROVIDED BY OPERATING ACTIVITIES | $4.0B | $3.5B | $5.1B | $8.1B |
| Cash from operations before working capital changes | $4.8B | $4.0B | $4.6B | $9.3B |
| Net earnings | $2.3B | $700.0M | $1.3B | $7.7B |
| Depreciation and amortization | $2.4B | $2.3B | $2.2B | $2.0B |
| Share-based compensation (Note 5) | $163.0M | $37.0M | ($14.0M) | $63.0M |
| (Recovery of) provision for deferred income tax | $250.0M | $31.0M | $7.0M | $182.0M |
| Other long-term assets, liabilities and miscellaneous (Note 16) | $12.0M | $311.0M | $277.0M | $21.0M |
| (Reversal of) impairment of assets | $0 | $530.0M | $774.0M | — |
| Adjustments For Undistributed Profits Of Investments Accounted For Using Equity Method Net Of Dividends | $65.0M | ($8.0M) | $117.0M | — |
| Loss related to Financial Instruments in Argentina | $0 | $35.0M | — | — |
| Long-term income tax receivable and payables | ($65.0M) | $47.0M | ($65.0M) | — |
| Loss on Sale of Investment | ($301.0M) | — | — | — |
| Receivables | ($128.0M) | ($224.0M) | $879.0M | ($919.0M) |
| Payables and accrued charges | ($98.0M) | ($323.0M) | ($1.7B) | $938.0M |
| Adjustments for Decrease Increase in Inventories, Prepaid Expenses and Other Current Assets | ($557.0M) | $60.0M | $1.4B | — |
| CASH USED IN INVESTING ACTIVITIES | ($1.4B) | ($2.1B) | ($3.0B) | ($2.9B) |
| Capital Expenditure | $2.0B | ($2.2B) | ($2.7B) | $2.4B |
| Additions to intangible assets | $123.0M | $129.0M | $206.0M | $211.0M |
| Capital Expenditures | $1.9B | $2.0B | $2.5B | $2.2B |
| Business acquisitions, net of cash acquired (Note 25) | ($23.0M) | ($21.0M) | ($153.0M) | ($407.0M) |
| Proceeds from disposal of investment in MOPCO (Note 15) | ($838.0M) | — | — | — |
| Other | ($61.0M) | $83.0M | ($20.0M) | ($12.0M) |
| Net Changes In Non Cash Working Capital | $6.0M | $27.0M | ($22.0M) | ($44.0M) |
| Purchase of Proceeds from Investments Held within three months | $33.0M | $44.0M | — | — |
| Purchase of Investments | $94.0M | ($112.0M) | — | — |
| CASH USED IN FINANCING ACTIVITIES | ($2.8B) | ($1.5B) | ($2.1B) | ($4.7B) |
| (Repayment of) proceeds from short-term debt, net (Note 17) | ($696.0M) | ($142.0M) | ($458.0M) | $529.0M |
| Proceeds from long-term debt (Note 18) | $998.0M | $1.0B | $1.5B | $1.0B |
| Repayment of long-term debt (Note 18) | ($1.1B) | ($659.0M) | ($648.0M) | ($561.0M) |
| Repayment of principal portion of lease liabilities (Note 18, 19) | ($419.0M) | ($402.0M) | ($375.0M) | ($341.0M) |
| Dividends paid (Note 23) | ($1.1B) | ($1.1B) | ($1.0B) | ($1.0B) |
| Repurchase of common shares (Note 23) | -551.0M | -184.0M | -1.0B | -4.5B |
| Issuance of common shares (Note 23) | 38.0M | 18.0M | 33.0M | 168.0M |
| Other financing activities | ($37.0M) | ($46.0M) | ($34.0M) | ($11.0M) |
| EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS | $30.0M | ($37.0M) | ($7.0M) | ($76.0M) |
| INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | ($152.0M) | ($88.0M) | $40.0M | $402.0M |
| CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR | $853.0M | $941.0M | $901.0M | $499.0M |
| CASH AND CASH EQUIVALENTS - END OF YEAR | $701.0M | $853.0M | $941.0M | $901.0M |
| Cash | $566.0M | $741.0M | $909.0M | $775.0M |
| Short-term investments | $135.0M | $112.0M | $32.0M | $126.0M |
| Cash and Cash equivalents total | $701.0M | $853.0M | $941.0M | $901.0M |
| Interest paid | $738.0M | $740.0M | $729.0M | $482.0M |
| Income taxes paid | $335.0M | $321.0M | $1.8B | $1.9B |
| Total cash outflow for leases | $567.0M | $558.0M | $501.0M | $459.0M |
Nutrien Ltd. score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.